Antiviral Activity of Catechin against Dengue Virus Infection
Viruses · 15.06.2023 · 15 (6) · 1377
DOI: 10.3390/v15061377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 15.06.2023. Verfasst von Bowen Yi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National U…. Hauptthemen laut MEDLINE: Dengue, Dengue Virus, Catechin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Riway (Singapore) Pte Ltd..
Abstract (Originalsprache)
Dengue virus (DENV) is the cause of dengue fever, infecting 390 million people worldwide per year. It is transmitted to humans through the bites of mosquitoes and could potentially develop severe symptoms. In spite of the rising social and economic impact inflicted by the disease on the global population, a conspicuous lack of efficacious therapeutics against DENV still persists. In this study, catechin, a natural polyphenol compound, was evaluated as a DENV infection inhibitor in vitro. Through time-course studies, catechin was shown to inhibit a post-entry stage of the DENV replication cycle. Further investigation revealed its role in affecting viral protein translation. Catechin inhibited the replication of all four DENV serotypes and chikungunya virus (CHIKV). Together, these results demonstrate the ability of catechin to inhibit DENV replication, hinting at its potential to be used as a starting scaffold for further development of antivirals against DENV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Infectious Disease Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
- Collaborative and Translation Unit for HFMD, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore.
ORCID-Profile: Benjamin Xuan Zheng Chew, Yuhui Deborah Fong, Chee Keng Mok, Justin Jang Hann Chu
Förderung
- Riway (Singapore) Pte Ltd.
Zitieren
APA
Yi, B., Chew, B. X. Z., Chen, H., Lee, R. C. H., Fong, Y. D., Chin, W. X., Mok, C. K., & Chu, J. J. H. (2023). Antiviral Activity of Catechin against Dengue Virus Infection. Viruses, 15(6), 1377. https://doi.org/10.3390/v15061377
Vancouver
Yi B, Chew BXZ, Chen H, Lee RCH, Fong YD, Chin WX, et al. Antiviral Activity of Catechin against Dengue Virus Infection. Viruses. 2023;15(6):1377. doi:10.3390/v15061377
BibTeX
@article{Yi2023,
author = {Yi, Bowen and Chew, Benjamin Xuan Zheng and Chen, Huixin and Lee, Regina Ching Hua and Fong, Yuhui Deborah and Chin, Wei Xin and Mok, Chee Keng and Chu, Justin Jang Hann},
title = {Antiviral Activity of Catechin against Dengue Virus Infection},
journal = {Viruses},
year = {2023},
volume = {15},
number = {6},
pages = {1377},
doi = {10.3390/v15061377}
}
EUVIMED